头颈部鳞状细胞癌颈动脉切除术后生存与并发症:系统综述与汇总分析
该系统综述与汇总分析纳入276例行颈总动脉或颈内动脉(CCA/ICA)切除的头颈部鳞状细胞癌(HNSCC)患者,中位随访11个月,汇总1年总生存率52.7%(95%CI 46.9-59.2),2年29.8%(95%CI 24.3-36.5),围手术期死亡率6.9%(n=19/276)。作者认为CCA/ICA切除可考虑用于经过准确选择的患者,并推荐开展多中心前瞻性研究以建立预测评分指导决策。
要点
- 276例HNSCC患者行CCA/ICA切除,中位随访11个月,1年与2年总生存率分别为52.7%与29.8%。
- 1年与2年疾病特异性生存率分别为58.6%与34.6%,中位疾病特异性生存16个月(95%CI 14-19)。
- 围手术期死亡率为6.9%(n=19/276),作者认为该手术可作为经过准确选择患者的治疗选择之一。
核心结论
- 作者认为,对于经过准确选择的患者,CCA/ICA切除应被视为一种治疗选择。
- 作者推荐开展多中心前瞻性研究,以建立指导决策过程的预测评分。
研究设计与样本
- 本研究为遵循PRISMA声明的系统综述与汇总分析,主要结局为总生存(OS)和疾病特异性生存(DSS),次要结局为围手术期死亡率。
- 共纳入276例因HNSCC行CCA/ICA切除的患者,男性76.7%(n=191/249),中位年龄59岁(n=239/276;95%CI 55.0-61.7),中位随访时间11个月(n=276)。
主要发现
- 汇总1年总生存率为52.7%(95%CI 46.9-59.2),2年总生存率为29.8%(95%CI 24.3-36.5),中位总生存14个月(95%CI 12-17)。
- 汇总1年疾病特异性生存率为58.6%(95%CI 52.7-65.2),2年疾病特异性生存率为34.6%(95%CI 28.5-41.9),中位疾病特异性生存16个月(95%CI 14-19)。
- 围手术期死亡率为6.9%(n=19/276)。
临床怎么用
- 作者认为CCA/ICA切除可考虑用于经过准确选择的HNSCC患者。
- 作者建议通过多中心前瞻性研究建立预测评分以指导治疗决策。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The aim of this study is to analyze oncologic outcomes and complications rate after common or internal carotid artery (CCA/ICA) resection for head and neck squamous cell carcinoma (HNSCC). METHODS: This study was conducted in conformity with the PRISMA statement. A systematic review and pooled analysis was performed for overall survival (OS), disease specific survival (DSS) (primary outcomes), and perioperative death rate (secondary outcome). RESULTS: A total of 276 patients (males: 76.7%, n = 191/249) with a median age of 59 years (n = 239/276; 95% CI 55.0-61.7) who underwent CCA/ICA resection for HNSCC were included. The median follow-up time was 11 months (n = 276). Estimated pooled OS rates (95% CI) at 1 and 2 years were 52.7% (46.9-59.2) and 29.8% (24.3-36.5), respectively. The median OS (95% CI) was 14 months (12-17). Estimated pooled DSS rates (95% CI) at 1 and 2 years were 58.6% (52.7-65.2) and 34.6% (28.5-41.9), respectively. The median DSS (95% CI) was 16 months (14-19). The perioperative death rate was 6.9% (n = 19/276). CONCLUSIONS: CCA/ICA resection should be considered as a treatment option for accurately selected patients. Multicentric prospective studies are recommended to develop a predictive score guiding the decision-making process.
引用
- Pace GM, Morales-Olavarría C, Costantino A, et al. Survival and complications after carotid resection for head and neck squamous cell carcinoma: A systematic review and pooled analysis. Head Neck. 2024. PMID: 38469988. doi:10.1002/hed.27723
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。